Pleckstrin homology domain of phospholipase D2 is a negative regulator of focal adhesion kinase
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Phospholipase D2 (PLD2) has been implicated in the tyrosine kinase-mediated signaling pathways, but the regulation events are yet to be identified. Herein, we demonstrate that pleckstrin homology (PH) domain of PLD2 (PLD2-PH) exerts an antitumorigenic effect via the suppression of PLD2 and focal adhesion kinase (FAK). The kinase domain of FAK interacts with PLD2-PH and induces tyrosine phosphorylation and activation of PLD2. Furthermore, PLD2 increased tyrosine phosphorylation of FAK. However, ectopic expression of the PLD2-PH competes for binding to FAK and reduces the interaction between PLD2 and FAK, thereby suppressing FAK-induced PLD activation and tyrosine phosphorylation of FAK. The PLD2-PH suppressed the migration and invasion of glioblastoma cells, as well as tumor formation in a xenograft mouse model. This study uncovers a novel role of PLD2-PH as a negative regulator of PLD2 and FAK.
Abstract
Phospholipase D2 (PLD2) has been implicated in the tyrosine kinase-mediated signaling pathways, but the regulation events are yet to be identified. Herein, we demonstrate that pleckstrin homology (PH) domain of PLD2 (PLD2-PH) exerts an antitumorigenic effect via the suppression of PLD2 and focal adhesion kinase (FAK). The kinase domain of FAK interacts with PLD2-PH and induces tyrosine phosphorylation and activation of PLD2. Furthermore, PLD2 increased tyrosine phosphorylation of FAK. However, ectopic expression of the PLD2-PH competes for binding to FAK and reduces the interaction between PLD2 and FAK, thereby suppressing FAK-induced PLD activation and tyrosine phosphorylation of FAK. The PLD2-PH suppressed the migration and invasion of glioblastoma cells, as well as tumor formation in a xenograft mouse model. This study uncovers a novel role of PLD2-PH as a negative regulator of PLD2 and FAK.
참고문헌 (26)
- Gomez-Cambronero J, "Phosphatidic acid, phospholipase D and tumorigenesis", Adv Biol Reg, 54, pp.197~206 (2014)
- Bruntz RC, "Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer", Pharmacol Rev, 66, pp.1033~1079 (2014)
- Nelson RK, "Physiological and pathophysiological roles for phospholipase D", J Lipid Res, 56, pp.2229~2237 (2015)
- Min DS, "Differential tyrosine phosphorylation of phospholipase D isozymes by hydrogen peroxide and the epidermal growth factor in A431epidermoid carcinoma cells", Mol Cells, 11, pp.369~378 (2001)
- Kang DW, "Functional regulation of phospholipase D expression in cancer and inflammation", J Biol Chem, 289, pp.22575~22582 (2014)
- Zhao C, "Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos", Nat Cell Biol, 9, pp.706~712 (2007)
- Frohman MA, "The phospholipase D superfamily as therapeutic targets", Trends Pharmacol Sci, 36, pp.137~144 (2015)
- Slaaby R, "PLD2complexes with the EGF receptor and undergoes tyrosine phosphorylation at a single site upon agonist stimulation", J Biol Chem, 273, pp.33722~33727 (1998)
- Ahn BH, "Transmodulation between phospholipase D and c-Src enhances cell proliferation", Mol Cell Biol, 23, pp.3103~3115 (2003)
- Brown HA, "Targeting phospholipase D in cancer, infection and neurodegenerative disorders", Nat Rev Drug Disv, 16, pp.351~367 (2017)
- Jang JH, "Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners", Prog Lipid Res, 51, pp.71~81 (2012)
- Lee CS, "The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis", Nat Cell Biol, 8, pp.477~484 (2006)
- Gomez-Cambronero J, "Biochemical and cellular implications of a dual lipase‐GEF function of phospholipase D2(PLD2)", J Leuko Biol, 92, pp.461~467 (2012)
- Park MH, "Phospholipase D1protein coordinates dynamic assembly of HIF-1-PHD-VHL to regulate HIF-1 stability", Oncotarget, 5, pp.11857~11872 (2014)
- Henkels KM, "A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation", Mol Cell Biol, 30, pp.2251~2263 (2010)
- Schaller MD, "pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk", Mol Cell Biol, 15, pp.2635~2645 (1995)
- Bae YS, "ATP-induced focal adhesion kinase activity is negatively modulated by phospholipase D2 in PC12 cells", Exp Mol Med, 33, pp.150~155 (2001)
- Min DS, "Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells", Neuropharmacology, 41, pp.384~391 (2001)
- Schaller MD, "Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src", Mol Cell Biol, 14, pp.1680~1688 (1994)
- Mitra SK, "Focal adhesion kinase : in command and control of cell motility", Nat Rev Mol Cell Biol, 6, pp.56~58 (2005)
- Lim Y, "Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts", J Biol Chem, 279, pp.29060~29065 (2004)
- Schwock J, "Targeting focal adhesion kinase signaling in tumor growth and metastasis", Expert Opin Ther Targets, 14, pp.77~94 (2010)
- 장희주, "STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells", BMB Reports, 51(11), pp.596~601 (2018), 생화학분자생물학회
- 박미희, "The pleckstrin homology domain of phospholipase D1 accelerates EGFR endocytosis by increasing the expression of the Rab5 effector, rabaptin-5", Experimental and Molecular Medicine, 47, pp.1~8 (2015), 생화학분자생물학회
- Bligh EG, "A rapid method of total lipid extraction and purification", Can J Bioochem Physiol, 37, pp.911~917 (1959)
- Park MH, "Overexpression of phospholipase D enhances matrix metalloproteinase-2expression and glioma cell invasion via protein kinase C and protein kinase A", NF-B, Carcinogenesis, pp.2009, 30[DOI]